Cancer Research Institute
Clinical Innovator
Protocol Concept deadline; invited full proposals due April 9, 2027; 11:59 p.m. Eastern Time
Last verified:
Details
| Funder | Cancer Research Institute |
| Budget | Up to $1M per trial |
| Deadline | 1 December 2026 |
| Consortium | No |
| Application | 2-stage: Initial Protocol Concept (Dec 1, 2026) → Invited Full Proposal (Apr 9, 2027) |
| Frequency | Annual |
Eligibility & scope
Funds investigator-initiated phase I/II or phase II immunotherapy clinical trials led by academic PIs. Open to researchers at medical schools or research centers in the US or abroad; no citizenship restrictions; for-profit institutions ineligible. Emphasis on novel immunotherapy, mechanistic insights, and biomarker discovery. Up to 10% indirect costs provided in addition to award. Co-funding available for chordoma-focused proposals (with Chordoma Foundation).
More from Cancer Research Institute
Immuno-Informatics Postdoctoral Fellowship
Deadline: 1 Sept 2026$74k–$78k/year stipend + $5k/year institutional allowance (3 years)CRI Immuno-Informatics Postdoctoral Fellowship
Deadline: 1 Sept 2026$243,000 totalCRI Irvington Postdoctoral Fellowship
Deadline: 1 Sept 2026$74k–$78k/year stipend + $5k/year institutional allowance (3 years)CRI Technology Impact Award
Deadline: 16 Nov 2026$600,000 totalTechnology Impact Award
Deadline: 16 Nov 2026Up to $600k over 2–4 years (+ up to 10% indirect costs)
Browse Related
Could Clinical Innovator be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →